Cite

HARVARD Citation

    Thielen, L. et al. (n.d.). Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP. Current opinion in endocrinology, diabetes and obesity. 25 (2), p. . [Online]. 
  
Back to record